BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26340601)

  • 1. Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer Chemotherapy.
    Rani R; Kumar V
    J Med Chem; 2016 Jan; 59(2):487-96. PubMed ID: 26340601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer metabolism to develop human lactate dehydrogenase (hLDH)5 inhibitors.
    Zhang SL; He Y; Tam KY
    Drug Discov Today; 2018 Jul; 23(7):1407-1415. PubMed ID: 29750903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors.
    Poli G; Granchi C; Aissaoui M; Minutolo F; Tuccinardi T
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29236080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule inhibitors of human LDH5.
    Granchi C; Paterni I; Rani R; Minutolo F
    Future Med Chem; 2013 Oct; 5(16):1967-91. PubMed ID: 24175747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.
    Granchi C; Roy S; De Simone A; Salvetti I; Tuccinardi T; Martinelli A; Macchia M; Lanza M; Betti L; Giannaccini G; Lucacchini A; Giovannetti E; Sciarrillo R; Peters GJ; Minutolo F
    Eur J Med Chem; 2011 Nov; 46(11):5398-407. PubMed ID: 21944286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When will small molecule lactate dehydrogenase inhibitors realize their potential in the cancer clinic?
    Rani R; Kumar V
    Future Med Chem; 2017 Jul; 9(11):1113-1115. PubMed ID: 28722474
    [No Abstract]   [Full Text] [Related]  

  • 7. A Virtual Screening Study for Lactate Dehydrogenase 5 Inhibitors by Using a Pharmacophore-based Approach.
    Tuccinardi T; Poli G; Corchia I; Granchi C; Lapillo M; Macchia M; Minutolo F; Ortore G; Martinelli A
    Mol Inform; 2016 Sep; 35(8-9):434-9. PubMed ID: 27546047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-aided discovery and biological characterization of human lactate dehydrogenase 5 inhibitors with anti-osteosarcoma activity.
    Cao W; Fang L; Teng S; Chen H; Wang Z
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2229-2233. PubMed ID: 29861142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.
    Granchi C; Roy S; Giacomelli C; Macchia M; Tuccinardi T; Martinelli A; Lanza M; Betti L; Giannaccini G; Lucacchini A; Funel N; León LG; Giovannetti E; Peters GJ; Palchaudhuri R; Calvaresi EC; Hergenrother PJ; Minutolo F
    J Med Chem; 2011 Mar; 54(6):1599-612. PubMed ID: 21332213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms.
    Kolappan S; Shen DL; Mosi R; Sun J; McEachern EJ; Vocadlo DJ; Craig L
    Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):185-95. PubMed ID: 25664730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of human lactate dehydrogenase 5 inhibitors (hLDH5) with anti-lung cancer activity through an in silico method and biological validation.
    He S; Wang Q
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2459-2463. PubMed ID: 31345633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting glycolysis: a fragment based approach towards bifunctional inhibitors of hLDH-5.
    Moorhouse AD; Spiteri C; Sharma P; Zloh M; Moses JE
    Chem Commun (Camb); 2011 Jan; 47(1):230-2. PubMed ID: 20676418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
    Chen CY; Feng Y; Chen JY; Deng H
    Bioorg Med Chem Lett; 2016 Jan; 26(1):72-5. PubMed ID: 26597536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors.
    Rupiani S; Buonfiglio R; Manerba M; Di Ianni L; Vettraino M; Giacomini E; Masetti M; Falchi F; Di Stefano G; Roberti M; Recanatini M
    Eur J Med Chem; 2015 Aug; 101():63-70. PubMed ID: 26114812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.
    Calvaresi EC; Granchi C; Tuccinardi T; Di Bussolo V; Huigens RW; Lee HY; Palchaudhuri R; Macchia M; Martinelli A; Minutolo F; Hergenrother PJ
    Chembiochem; 2013 Nov; 14(17):2263-7. PubMed ID: 24174263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials.
    Granchi C; Bertini S; Macchia M; Minutolo F
    Curr Med Chem; 2010; 17(7):672-97. PubMed ID: 20088761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and initial screening of lactate dehydrogenase inhibitor activity of 1,3-benzodioxole derivatives.
    Annas D; Cheon SY; Yusuf M; Bae SJ; Ha KT; Park KH
    Sci Rep; 2020 Nov; 10(1):19889. PubMed ID: 33199724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a docking-based virtual screening platform for the identification of new lactate dehydrogenase inhibitors.
    Granchi C; Capecchi A; Del Frate G; Martinelli A; Macchia M; Minutolo F; Tuccinardi T
    Molecules; 2015 May; 20(5):8772-90. PubMed ID: 25988609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lactate dehydrogenase activity as an approach to cancer therapy.
    Fiume L; Manerba M; Vettraino M; Di Stefano G
    Future Med Chem; 2014 Mar; 6(4):429-45. PubMed ID: 24635523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Label-free high-throughput assays to screen and characterize novel lactate dehydrogenase inhibitors.
    Vanderporten E; Frick L; Turincio R; Thana P; Lamarr W; Liu Y
    Anal Biochem; 2013 Oct; 441(2):115-22. PubMed ID: 23871998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.